ALSO NOTED: JHP takes over King Pharma plant; AstraZeneca expands giveaway program

> King Pharma sold off its Rochester, Michigan, manufacturing plant to JHP Pharmaceuticals for $93 million in cash; JHP will take on the plant employees and contract manufacturing there. Release

> AstraZeneca is adding 150 more facilities to its list of healthcare providers that get free AZ drugs for low-income patients. Report

> A new study shows that flu shots do benefit patients 65 and older, adding fuel to the argument over the efficacy of the vaccines in the elderly. Report

> The Irish pharmaceuticals distributor United Drug says its year-end profits will beat market expectations, with double-digit year-over-year sales growth. Report

> Three of Europe's biggest drugmakers have teamed up with the British government to launch Stem Cells for Safer Medicines (SC4SM), a non-profit that will develop stem cells for safety testing of new drugs. Report

And Finally... Oh, the tangled web of intellectual property claims woven by stent makers since the devices were born in 1994. With $6.5 billion in annual sales at stake, no wonder so many companies are fighting over who owns what. Article

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.